Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Melanoma Research|June 28, 2017
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experienceFrancesco de Rosa, Laura Ridolfi, Laura Fiammenghi, et al.Cytotherapy|July 24, 2024
Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal productsAnna Maria Granato, Elena Pancisi, Claudia Piccinini, et al.BMC Cancer|November 22, 2025
CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancerAlessandro Passardi, Francesco Giulio Sullo, Alessandro Bittoni, et al.Frontiers in Oncology|October 5, 2023
High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literatureGiacomo Miserocchi, Massimo Bassi, Giovanni De Luca, et al.Journal of Experimental & Clinical Cancer Research : CR|April 9, 2014
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programmeVanna Chiarion Sileni, Jacopo Pigozzo, Paolo Antonio Ascierto, et al.Frontiers in Immunology|November 15, 2021
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell CarcinomaJenny Bulgarelli, Claudia Piccinini, Elisabetta Petracci, et al.Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.Frontiers in Oncology|September 1, 2022
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup StudyRiccardo Marconcini, Paolo Fava, Amedeo Nuzzo, et al.Cancer Investigation|February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access programPaolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.Journal of Experimental & Clinical Cancer Research : CR|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanomaMarcella Tazzari, Silvia Carloni, Jenny Bulgarelli, et al.Pageof 6